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Abstract
Background: Macropinocytosis is an actin-driven endocytic process, whereby membrane ruffles fold back onto the plasma
membrane to form large (.0.2 mm in diameter) endocytic organelles called macropinosomes. Relative to other endocytic
pathways, little is known about the molecular mechanisms involved in macropinocytosis. Recently, members of the Sorting
Nexin (SNX) family have been localized to the cell surface and early macropinosomes, and implicated in macropinosome
formation. SNX-PX-BAR proteins form a subset of the SNX family and their lipid-binding (PX) and membrane-curvature
sensing (BAR) domain architecture further implicates their functional involvement in macropinosome formation.
Methodology/Principal Findings: We exploited the tractability of macropinosomes through image-based screening and
systematic overexpression of SNX-PX-BAR proteins to quantitate their effect on macropinosome formation. SNX1 (40.9+/
23.19 macropinosomes), SNX5 (36.99+/24.48 macropinosomes), SNX9 (37.55+/22.4 macropinosomes), SNX18 (88.2+/28
macropinosomes), SNX33 (65.25+/26.95 macropinosomes) all exhibited statistically significant (p,0.05) increases in
average macropinosome numbers per 100 transfected cells as compared to control cells (24.44+/21.81 macropinosomes).
SNX1, SNX5, SNX9, and SNX18 were also found to associate with early-stage macropinosomes within 5 minutes following
organelle formation. The modulation of intracellular PI(3,4,5)P3 levels through overexpression of PTEN or a lipid
phosphatase-deficient mutant PTEN(G129E) was also observed to significantly reduce or elevate macropinosome formation
respectively; coexpression of PTEN(G129E) with SNX9 or SNX18 synergistically elevated macropinosome formation to
119.4+/27.13 and 91.4+/26.37 macropinosomes respectively (p,0.05).
Conclusions/Significance: SNX1, SNX5, SNX9, SNX18, and SNX33 were all found to elevate macropinosome formation and
(with the exception of SNX33) associate with early-stage macropinosomes. Moreover the effects of SNX9 and SNX18
overexpression in elevating macropinocytosis is likely to be synergistic with the increase in PI(3,4,5)P3 levels, which is known
to accumulate on the cell surface and early-stage macropinocytic cups. Together these findings represent the first
systematic functional study into the impact of the SNX-PX-BAR family on macropinocytosis.
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Introduction
Macropinocytosis is a high-capacity variant of endocytic uptake
first reported by Warren Lewis in 1931 [1], generating large
endocytic organelles termed macropinosomes through actin-
driven evaginations of the plasma membrane. Unlike clathrin-
mediated endocytosis or phagocytosis, macropinocytosis is not
regulated by the binding of cargo to the receptors which then
recruit effector molecules that aid in vesicle formation [2]; instead
the activation of receptor tyrosine-kinases (RTK) in response to
growth factor treatment drives the actin-mediated ruffling of the
plasma membrane, non-selectively engulfing large volumes of fluid
to form phase bright macropinosomes larger than 0.2 mmi n
diameter [1,3]. Strikingly, this heterogeneous size range is
significantly larger than other endocytic compartments such as
clathrin-coated vesicles (852110 nm), caveolae (55275 nm), and
clathrin-independent carrier/Glycosylphosphatidylinositol (GPI)-
anchored protein-enriched early endosomal compartments
(CLIC/GEEC) (40280 nm), which together with its mechanism
of formation distinguishes macropinocytosis from other endocytic
pathways [4,5,6,7,8].
The rapid and large fluid-carrying capacity of macropinocytosis is
central to its many diverse physiological roles. Within the immune
response, macropinocytosis is particularly active within antigen-
presenting cells before presenting the antigenic peptides on the cell
surface [9]. Cells overexpressing oncogenes have also been shown to
exhibit elevated levels of macropinocytosis [10,11,12], and treatment
with growth factors associated with uncontrolled cell proliferation in
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Moreover due to its non-specific and high capacity nature of fluid
intake, macropinocytosis is an ideal route for pathogens to hijack in
order to gain entry into the cell [17]. The invasion of Salmonella enterica
Serovartyphimurium[18,19],Shigellaflexneri[20,21,22],Mycobacterium
[23], Vacciniavirus[24], and Coxsackievirus [25] have all been connected
to the exploitation of macropinocytosis.
Despite its significant physiological implications, there is a
paucity of knowledge regarding macropinocytosis relative to other
endocytic pathways; this can be largely attributed to the inability
to definitively characterize macropinosomes through a stable
association between the organelle and specific proteins or lipids. It
is known however that treatment with millimolar concentrations of
the ion exchange inhibitor amiloride inhibits macropinocytosis but
not clathrin-mediated endocytosis [26]. Amiloride has been
associated with the lowering of submembranous pH and
preventing Rho GTPase signalling and actin remodeling [27],
both of which are essential for the membrane ruffling necessary for
macropinocytosis. This property can be used to define macro-
pinocytosis along with the size of the organelle and responsiveness
to growth factor stimulation [3].
PI(3)K activity has also been shown to be required for
macropinosome formation [10,28], implicating the direct role of
its phosphorylation targets, 3-phosphoinositides, in the process.
Phosphoinositides (PI) result from the phosphorylation of phospha-
tidylinositol at different positions along the inositol ring [29], and
different phosphoinositide species are crucial for the formation and
maturation of macropinosomes. PI(4,5)P2 levels on membrane
ruffles have been observed to be more than double the amount
present on planar membranes, rapidly dropping just prior to
macropinosome closure [30]. Conversely, PI(3,4,5)P3 levels increase
locally at the site of macropinosome formation and peak when the
macropinosome closes [30,31] and the subsequent drop in
PI(3,4,5)P3 levels coincides with the accumulation of PI(3)P on the
body of the macropinosome [32]. Rab5 and its effectors have been
implicated in this stage of the macropinosome lifecycle, as Rab5
recruitment to the macropinosome occurs prior to PI(3,4,5)P3 loss
[31], and it is known to interact with Vps34-p150 to synthesize
PI(3)P [33]. Moreover the Rab5 effector Rabankyrin-5 binds to
PI(3)P by virtue of its FYVE domain, and is directly involved in
regulating macropinosome formation; the overexpression and
siRNA-mediated depletionofRabankyrin-5increasesanddecreases
the number of macropinosomes formed, respectively [34].
Given the precise spatiotemporal regulation of the phosphoino-
sitide composition on the macropinosome body at different stages
in its lifecycle, proteins that bind to and/or regulate the synthesis
of phosphoinositides would potentially be involved in macro-
pinocytosis. The Phox homology (PX) domain is a 1002140
residue phosphoinositide-binding domain that has been found in
15 yeast proteins and 47 mammalian proteins [35]. Its most well-
established function is targeting proteins to phosphoinositide-rich
membranes; all 15 PX-domain proteins in yeast have been shown
to interact specifically with PI(3)P [36] and many of the
mammalian PX-domain proteins bind to a wide variety of
phosphoinositide species [37,38,39,40,41,42,43,44,45,46]. Of the
47 mammalian PX-domain proteins, 30 are within the Sorting
Nexin family [35]. A subset of the Sorting Nexin family also
contains a C-terminal Bin/Amphiphysin/Rvs (BAR) domain,
proposed to be involved in protein dimerization, sensing
membrane curvature, and membrane tubulation [47,48,49,50].
It was further demonstrated that as a mechanism of protein
targeting and recruitment, the PX and BAR domains cooperate in
the coincidence detection of highly-curved phosphoinositide-rich
membranes [43,51]. 12 out of the 30 Sorting Nexins contain both
PX and BAR domains - SNX1, SNX2, SNX4, SNX5, SNX6,
SNX7, SNX8, SNX9, SNX18, SNX30, SNX32 and SNX33;
collectively these proteins form the SNX-PX-BAR family. Three
of the SNX-PX-BAR proteins also possess an additional N-
terminal SH3 domain – SNX9, SNX18 and SNX33. Together,
these three proteins form the SH3-PX-BAR subgroup.
We have previously demonstrated that SNX5 is involved early
in the macropinocytic lifecycle, regulating the formation of
macropinosomes at the cell surface [14,52]. SNX5 is transiently
recruited to the plasma membrane in response to EGF [45], a
physiological treatment known to upregulate macropinocytosis
[13]. This is likely due to the elevation in PI(3,4)P2 on the plasma
membrane following EGF treatment, to reflect the PI(3,4)P2-
specificity of the PX domain of SNX5 [45]. Following its cell-
surface translocation, SNX5 can be localized to discrete
subdomains of the macropinosome along with Rab5 and
Rabankyrin-5 early in the macropinosome lifecycle, forming
extensive microtubule-dependent tubules that depart from the
macropinosome body [14]. This extensive tubulation removes a
significant portion of the limiting membrane of the macropino-
some, and is a potential mechanism for rapid membrane and
protein trafficking back to the cell surface to facilitate further
macropinocytic events; this model is consistent with our
observation that the stable overexpression of SNX5 led to a 2-
fold elevation in macropinosome formation [52].
Within this study, we aimed to extend our understanding of the
molecular coordination involved in regulating macropinocytosis by
discovering novel molecules that influence macropinosome forma-
tion. We hypothesize that proteins that share the PX and BAR
domainarchitecture ofSNX5– theSNX-PX-BAR family- mayalso
be involved in macropinocytosis. The twelve members of the SNX-
PX-BAR family were systematically assayed using a quantitative
image-based assay for macropinosome formation, and it was
observed that five candidates within the family - SNX1, SNX5,
SNX9, SNX18 and SNX33 - all elevated macropinosome
formation. Of these five candidates, only SNX1, SNX5, SNX9,
and SNX18 could be found to associate with early-stage macro-
pinosomes five minutes post formation, whereas SNX33 was
observed to be cytosolic in its subcellular distribution. The
connection between the phosphoinositide-binding capacity of the
PX-BAR domain and its ability to influence macropinosome
formation was further investigated by modulating the levels of
PI(3,4,5)P3, which has been localized to the macropinocytic cup very
early in the formation process [31]. Overexpression of Phosphatase
and tensin homolog (PTEN), the metabolic enzyme which catalyzes
the dephosphorylation of PI(3,4,5)P3 to PI(4,5)P2, or a lipid
phosphatase-deficient mutant PTEN(G129E), significantly de-
creased or increased macropinosome formation respectively. More-
over coexpressing PTEN(G129E)with either SNX9orSNX18, both
reported topreferentiallybindPI(4,5)P2throughtheirrespective PX-
BAR domains [46], resulted in a synergistic elevation in macro-
pinosome formation. These results suggest a mechanistic link may
exist between the conversion from PI(4,5)P2 to PI(3,4,5)P3 and SNX-
PX-BAR proteins that are able to selectively bind to these
phosphoinositides in the regulation of macropinosome formation.
The results of this screen represent the first functional study of the
SNX-PX-BAR family in macropinocytosis, as well as implicating
the role of phosphoinositide levels in macropinosome formation.
Results
Screening Assay Development and Validation
To test the hypothesis that the SNX-PX-BAR family is involved
in macropinocytosis, a functional assay was developed in order to
SNX’s Role in Macropinocytosis
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exploit the visual tractability of macropinosomes via light
microscopy to develop an image-based quantitative assay for
macropinosome formation. Cells were transfected with the protein
of interest and treated to specific cellular conditions before being
pulsed for 5 minutes with fluorescently-conjugated dextran
(10,000 MW). This time point was selected as macropinosomes
formed in this period show limited maturation [14,52]. The samples
were then processed for confocal imaging and quantitated through
an automated image analysis protocol (Figure 1A). Briefly, for each
field of view the channels corresponding to GFP and dextran
fluorescence were captured (Figure 1Ai). The total number of
dextran-positive macropinosomes within the field of view was then
quantified by size (.0.5 mm in diameter) and fluorescent intensity
(.100) (Figure 1Aii and Aiii). Each macropinosome was then used
as a mask to create a region of interest within the image, and
correlated to the same position within the green channel
(Figure 1Aiv). This allowed the measurement of the green
fluorescent intensity at the position of each macropinosome within
the image, and any intensity higher than background signal (.20)
was indicative of presence within a GFP-positive transfected cell.
Other macropinosomes that correlated to green intensities below
this threshold were discarded. The green channel also allowed for
the calculation of the number of transfected cells within the field of
view, and the mean number of macropinosomes per100 transfected
cells was measured for each overexpressed construct.
To validate the specificity and sensitivity of this methodology,
we applied the screening assay to cellular conditions and proteins
of interest known to regulate macropinocytosis. EGF has been
shown to rapidly stimulate macropinocytosis [13], and using the
assay developed, a 2 fold increase in macropinosome formation
(p,0.05) was observed in serum-starved cells treated with 100 ng/
mL EGF for 5 minutes relative to control samples (Figure 1B).
Treatment with 1 mM Amiloride, a disruptor of Na+/H+
exchange known to specifically inhibit macropinocytosis [26],
resulted in a 4.54 fold drop in macropinosome number (p,0.05)
relative to cells treated with carrier (0.6% Methanol), indicating
that the structures visualized through the assay are amiloride-
sensitive (Figure 1C). Moreover upon overexpression of pEGFP-
SNX5, which has been reported to be localized on early-stage
macropinosomes [14] as well as regulating the rate at which
macropinosomes are formed [52], a 1.5 fold increase in
macropinosome formation (p,0.05) was observed compared to
cells expressing pEGFP-C1 (Figure 1D). Together these results
suggest that the structures as detected by the screening assay are
transiently upregulated by EGF treatment, and sensitive to
amiloride-mediated inhibition of macropinocytosis, both of which
are hallmarks specific to macropinocytosis [3]. Furthermore the
screening assay is sufficiently sensitive to detect an elevation in
macropinosome formation upon overexpression of SNX5, a
known regulator of macropinosome formation [52].
Rab5 and its downstream effector Rabankyrin 5 are also
regulators of macropinocytosis [34] and were overexpressed in
HEK-Flp-In cells and pulsed with dextran for 5 minutes. Large
macropinosomes could be seen at this early timepoint which are
positive for GFP-Rab5, and the same was observed for YFP-
Rabankyrin-5 (Figure 2A), consistent with their localization in
EGF-stimulated A431 cells [34]. Moreover the specificity of the
assay was contingent on the significantly larger size of macro-
pinosomes (0.2 to 5 mm in diameter) relative to other endocytic
organelles (up to 0.1 mm in diameter), but it was formally possible
for the promotion of homotypic fusion to increase the size of
smaller endosomes. To test this, the constitutively active Rab5-
Q79L mutant known to promote endosomal homotypic fusion
[53], was overexpressed in HEK-Flp-In cells. Enlarged endosomes
were observed in pEGFP-Rab5-Q79L-expressing cells within the
diameter range of macropinosomes, but after 5 minutes of dextran
uptake, none of these structures were dextran positive (Figure 2B).
This indicates that under these conditions, the enlarged endo-
somes were the result of homotypic fusion between intracellular
early endosomes, which can be specifically distinguished from
large dextran-positive macropinosomes derived from the cell
surface following 5 minutes of uptake.
Utilising the screening assay, a 1.7 fold elevation in macro-
pinocytosis (p,0.05) was observed in pEGFP-Rab5 overexpress-
ing cells relative to pEGFP-C1-overexpressing cells. Moreover a 3
fold elevation in macropinosome formation (p,0.05) was observed
for cells overexpressing pEYFP-Rabankyrin-5 (Figure 2C). The
difference in the degree of macropinocytosis elevation was
consistent with Rabankyrin-5 being a downstream effector of
Rab5 that is directly involved in macropinocytosis [34]; elevating
Rab5 levels would promote the activation of an existing
endogenous pool of Rabankyrin-5, whereas elevating Raban-
kyrin-5 would have a direct and more pronounced effect on
macropinocytosis. No difference was observed in macropinocytosis
between cells expressing pEGFP-C1 or pEGFP-Rab5-Q79L,
further indicating that the enlarged endosomes are not detected
as false positives within the assay.
SNX1, SNX5, SNX9, SNX18 and SNX33 are involved in
macropinosome formation
Following the validation of the screening assay using the known
regulators of macropinocytosis, the gain-of-function macropino-
some formation screen was conducted on each member of the
SNX-PX-BAR family. 24 hours following the transfection, cells
were assayed for macropinosome formation across 8 replicates of
at least 500 transfected cells per construct in order to obtain the
average macropinosomes formed/100 transfected cell. Relative to
the macropinosomes formed in cells overexpressing pEGFP-C1,
pEGFP-SNX1, pEGFP-SNX5 and pEGFP-SNX9 overexpressing
cells all exhibited a 2 fold elevation in macropinocytosis (Figure 3A
and B). SNX5 [14,52] and SNX9 [40] have both been implicated
in macropinosome formation, so they serve as positive controls for
the sensitivity of the assay. The promotion of macropinosome
formation following SNX1 overexpression is also consistent with
its interaction with SNX5 [14], and presumably the two proteins
regulate macropinocytosis through a common mechanism. The
overexpression of pEGFP-SNX18 and pEGFP-SNX33 also
resulted in 3.6 and 2.7 fold elevations in macropinocytosis
respectively (Figure 3). Therefore the increased levels of SNX1,
SNX5, SNX9, SNX18 and SNX33 all significantly elevated the
number of macropinosomes formed. with the SH3-PX-BAR
subgroup showing the highest elevations. Quantitative fluores-
cence analysis captured under identical non-saturating conditions
revealed no significant difference between total GFP fluorescence
across cell monolayers overexpressing pEGFP-SNX9, pEGFP-
SNX18, or pEGFP-SNX33.
The question posed next was whether or not these SNX-PX-
BAR proteins could be found to be associated with newly formed
macropinosomes. Cells were pulsed with dextran for 5 minutes,
and the association of SNX1, SNX5, SNX9, SNX18 and SNX33
with macropinosomes was observed by high resolution confocal
microscopy. SNX1 and SNX5 could be observed colocalizing with
each other on discrete patches of the newly formed macropino-
some (Figure 4A), and both SNX9 (Figure 4B) and SNX18
(Figure 4C) could be found on these early stage macropinosomes
as well. SNX33 however, could not be observed being recruited
onto any membrane within the cell, remaining cytosolic in
SNX’s Role in Macropinocytosis
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13763Figure 1. Macropinosome formation screening assay validation. A: 24 hours post transfection, HEK-Flp-In cell monolayers were pulsed for 5
minutes with 100 mg/mL dextran (10,000 MW) conjugated to tetramethylrhodamine (dextran-TR) at 37uC. The samples were then washed in 4uC PBS,
fixed in 4% PFA and imaged and processed as described in Materials and Methods. Briefly Z-stack images comprising of 365 mm Z slices were
merged into a single RGB image of transfected cells (green) stained with dextran-TR (red) (Ai). The red channel from the RGB image was isolated and
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that SNX1, SNX5, SNX9, and SNX18 regulate the formation of
macropinosomes early in their lifecycle, as they can be found on
the macropinosome body shortly after formation.
Following on from the observation that all the members of the
SH3-PX-BAR subgroup – SNX9, SNX18, and SNX33 -
upregulated macropinosome formation when overexpressed, we
decided to specifically investigate the contribution of the SH3
domain within these proteins towards elevating macropinosome
formation. Detailed functional protein domain analyses have
previously been conducted for both SNX9 [41] and SNX33 [54],
so we decided to focus on SNX18. We generated a pEGFP-DSH3-
SNX18 construct where the first 60 residues corresponding to the
SH3 domain have been deleted. This construct was then
transfected into HEK-Flp-In cells, and assayed for its impact on
macropinosome formation. It was observed that unlike the
overexpression of pEGFP-SNX18, the elevation of pEGFP-
DSH3-SNX18 did not result in a statistically significant increase
in macropinosome numbers compared to cells expressing pEGFP
(Figure 5). This suggests that the SH3 domain of SNX18 is
required for SNX18-induced upregulation of macropinosome
formation.
Modulating PI(3,4,5)P3 levels affects macropinosome
formation
The PX-BAR modules of SNX9 and SNX18 have specifically
been reported to bind PI(4,5)P2 [46], a phosphoinositide which
transiently increases in concentration on membrane ruffles before
dropping in accordance with the subsequent enrichment of
PI(3,4,5)P3 on the cell surface and the macropinocytic cup
[30,31,32]. Given the necessity for PI(3)K activity in macropino-
some formation [10,28], the spatiotemporal distribution of these
phosphoinositides early in the macropinocytic lifecycle, and the
PI(4,5)P2 binding specificity of SNX9 and SNX18, we hypothe-
sized that the regulation of phosphoinositide levels may play a
significant role in the mechanism by which SNX9 and SNX18
upregulates macropinocytosis.
We investigated the validity of this hypothesis by first pre-
treating cells with 65 mM LY294002 for 30 minutes to inhibit
PI(3)K activity, and assessing the effect of this treatment on
macropinosome formation relative to the carrier (0.2% ethanol). A
4-fold decrease in macropinosome formation (p,0.05) was
observed in LY294002-treated cells as compared to carrier-treated
samples (Figure 6A), consistent with previous observations [55].
We then examined the effect of inhibiting PI(3)K activity on the
subcellular distribution of PI(3,4,5)P3 by transiently expressing a
GFP fusion protein of the Grp1 PH domain (GFP-Grp1-PH),
which has been reported to specifically bind PI(3,4,5)P3 [56]. GFP-
Grp1-PH was observed on the plasma membrane in untreated
cells (Figure 6B), consistent with previous reports that PI(3,4,5)P3 is
localized on the cell surface [57]. Within 3 minutes of treatment
with LY294002, the cell-surface labeling of GFP-Grp1-PH was
ablated, and its distribution throughout the cell became predom-
inantly cytosolic (Figure 6B). Together these results suggest the
possibility that PI(3)K activity is required to maintain the levels of
PI(3,4,5)P3 on the cell surface in order for macropinosome
formation to occur.
We further investigated the role of PI(3,4,5)P3 levels in
macropinosome formation by using the PI(3,4,5)P3 phosphatase
PTEN to modulate intracellular PI(3,4,5)P3 [58]. Compared to
cells transfected with the empty pIRES2-EGFP and pmCherry
vectors, cells co-expressing pmCherry and pIRES2- EGFP -PTEN
exhibited a 2-fold decrease in the number of macropinosomes
formed (p,0.05) using the screening assay (Figure 6C). This
suggests that by overexpressing pIRES2-EGFP-PTEN and thus
promoting the dephosphorylation of the existing intracellular pool
of PI(3,4,5)P3 to PI(4,5)P2, macropinosome formation was
significantly attenuated. Moreover when the phosphatase-deficient
mutant of PTEN, pIRES2-EGFP-PTEN(G129E) was co-ex-
pressed with the empty pmCherry vector, a 2 fold elevation in
macropinocytosis was observed relative to control cells (p,0.05).
PTEN(G129E) still possesses the capacity to bind PI(3,4,5)P3 but is
unable to catalyse its dephosphorylation [59]. Elevated levels of
PTEN(G129E) may competitively bind to, but not dephosphor-
ylate PI(3,4,5)P3 thus lowering the rate at which PI(3,4,5)P3 is
metabolized within the cell by endogenous PTEN and transiently
elevating intracellular PI(3,4,5)P3. Intriguingly, cells coexpressing
pIRES2-EGFP-PTEN(G129E) and pmCherry-SNX9 further ex-
aggerated the already elevated levels of macropinosome formation
in pmCherry-SNX9 and pIRES2-EGFP-coexpressing cells by 2.7
fold (p,0.05) (Figure 6C).The same was observed for cells
coexpressing pmCherry-SNX18 and pIRES2-EGFP-
PTEN(G129E), elevating macropinosome formation by 1.5 fold
over pmCherry-SNX18 and pIRES2-EGFP coexpressing cells
(p,0.05) (Figure 6C). Interestingly coexpression of pIRES2-
EGFP-PTEN with either pmCherry-SNX9 or pmCherry-
SNX18 did not significantly alter the frequency of macropinosome
formation as compared to cells coexpressing pIRES2-EGFP with
pmCherry-SNX9 or pm-Cherry-SNX18 respectively (Figure 6C);
this is possibly because elevating the levels of SNX9 or SNX18 is
able to overcome the lowering of intracellular PI(3,4,5)P3 in
regulating macropinosome formation. These data suggests that the
actions of PTEN(G129E) in potentially elevating intracellular
PI(3,4,5)P3 are synergistic with SNX9 and SNX18 in elevating
macropinosome formation, implicating the role of PI(3,4,5)P3 in
SNX9 and/or SNX18-mediated regulation of macropinosome
formation.
Discussion
In this study, we utilized image-based quantitative analyses to
implement a gain-of-function screening assay for assessing
macropinosome formation. The sensitivity of the assay was
validated by detecting an acute 2 fold elevation in macropinosome
converted to an 8-bit grayscale image (Aii). Dextran-positive macropinosomes were selected based on size (.0.5 mm in diameter) and fluorescent
intensity (.100). Selected macropinosomes are shown in the foreground as black (Aiii). This binary image was then converted to a mask and
superimposed onto the Green channel of the original RGB image to measure the green fluorescent intensity of the area occupied by each
macropinosome in the image (Aiv). The particles with green fluorescence intensity higher than background signal (.20) were considered to be
macropinosomes within a transfected cell, represented in green. Red particles represent discarded macropinosomes determined to be outside of a
transfected cell. Scale =10 mm. B, C, D: HEK-Flp-In cell monolayers were either serum-starved for 16 hours and treated with dextran-TR in the
presence or absence of 100 ng/mL EGF for 5 minutes at 37uC (B), treated with 1 mM amiloride or carrier (0.6% Methanol) for 30 minutes at 37uC
before pulsing with dextran-TR (C), or transiently transfected with pEGFP-C1 or pEGFP-SNX5 before pulsing with dextran-TR (D). The samples in each
case were assayed for macropinosome formation as described in Materials and Methods, quantitating the mean number of macropinosomes/100
transfected cells over 3 replicates of 500 transfected cells for each condition. * denotes statistical significance (p,0.05) using the Student’s T-test.
Error bars denote Standard Error of the Mean (S.E.M).
doi:10.1371/journal.pone.0013763.g001
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PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13763Figure 2. Rab5 and Rabankyrin5 overexpression increases macropinosome formation. The distribution of Rab5, Rabankyrin-5 (A) or
Rab5(Q79L) (B) in green relative to dextran-positive macropinosomes (red) Scale bar =10 mm. (C) HEK-Flp-In cells were transiently transfected with
pEGFP-C1, pEGFP-Rab5, pEGFP-Rab5-Q79L and pEYFP-Rabankyrin-5. The mean number of macropinosomes/100 transfected cells was quantitated
over 3 replicates of 500 transfected cells for each condition. * denotes statistical significance (p,0.05) using the Student’s T-test, performing pairwise
analyses relative to cells transfected with pEGFP-C1 alone. Error bars denote S.E.M.
doi:10.1371/journal.pone.0013763.g002
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in macropinosome numbers upon amiloride treatment. The assay
was also tested against the overexpression of known regulators of
macropinocytosis; transient overexpression of SNX5 significantly
increased macropinosome formation, as did Rab5 and Raban-
kyrin-5 overexpression. Moreover given that Rabankyrin-5 is a
Rab5 effector, the significantly higher levels of macropinocytosis in
Rabankyrin-5 overexpressing cells relative to those overexpressing
Rab5 demonstrates the sensitivity of the screening assay in
detecting the quantitative difference between modulating up-
stream and downstream components of the macropinocytic
pathway.
The capacity of the assay to specifically quantify macropinocy-
tosis and not other endocytic pathways was also validated. The
main distinguishing factors of macropinosomes are their large size
relative to other endocytic organelles (0.2–5 mm as compared to up
to 200 nm in diameter) and their derivation from the plasma
membrane. Overexpression of the Rab5Q79L mutant is known to
promote homotypic endosomal fusion [53,60], resulting in the
formation of large endocytic structures that fulfill the size criterion
of macropinosomes. Only dextran-positive structures formed
within 5 minutes of dextran uptake were counted in the assay
however, and the Rab5-Q79L-positive enlarged endosomes were
not found to associate with any dextran-positive macropinosomes.
Moreover Rab5-Q79L overexpression had no detectable impact
on macropinosome formation. These data provide assurance that
the dextran-positive structures quantified in the screening assay
are derived from the cell surface and not a result of the homotypic
Figure 3. The SNX-PX-BAR family is involved in macropinosome formation. HEK-Flp-In cells transiently overexpressing GFP-tagged
members of the SNX-PX-BAR family were assayed for macropinosome formation as described in Materials and Methods. A: Dextran-TR labeling of
cells transfected with the specified constructs. Scale bar =10 mm. B: The mean number of macropinosomes/100 transfected cells was quantitated
over 8 replicates of 500 transfected cells for each condition. * denotes statistical significance (p,0.05) using the Student’s T-test, performing pairwise
analyses relative to cells transfected with pEGFP-C1 alone. Error bars denote S.E.M.
doi:10.1371/journal.pone.0013763.g003
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specificity in measuring macropinocytosis.
Following their formation at the cell surface, macropinosomes
undergo a series of maturation events before either recycling back
to the cell surface [61], or fusing with the late endosomes/
lysosomes [62]. The intracellular fate of macropinosomes is largely
dependent on cell-type; in A431 cells, macropinosomes recycle
back to the plasma membrane [61] whereas within macrophages,
macropinosomes progressively acquire molecules conferring early
and late endosomal identity, finally being delivered to the late
endosome/lysosome [62]. HEK-Flp-In cells were used as the
experimental system within this study and have been previously
observed to possess a macropinocytic lifecycle similar to that of
macrophages [63], with very infrequent macropinosome recycling
events as monitored by time-lapse video microscopy. It is therefore
unlikely that macropinosome recycling back to the cell surface
within our experimental system would confound the measurement
of macropinosome formation.
Additionally, the screening assay defines newly formed macro-
pinosomes as endocytic organelles .0.5 mm in diameter formed
within a 5 minute window of dextran internalisation. These size
and temporal criteria minimize the likelihood that downstream
maturation events within the macropinocytic lifecycle may
confound the measurement of macropinosome formation. As
evidenced by the inability of Rab5-Q79L overexpression to
influence macropinosome formation, the contribution of homo-
Figure 4. SNX1, SNX5, SNX9 and SNX18 associate with early macropinosomes. A: HEK-Flp-In cells were pulsed with 100 mg/mL dextran
(10,000 MW) conjugated to Alexa-647 (dextran-647) for 5 minutes before being transferred to 4uC and washed with 0.45 mM CaCl2 1 mM MgCl2 PBS.
The cells were then treated with 80 U/mL Streptolysin O for 5 minutes at 4uC to only permeabilize the plasma membrane before washing in 0.45 mM
CaCl2 1 mM MgCl2 PBS and incubating with 37uC PBS for 5 minutes. Following fixation with 4% PFA for 30 minutes at 4uC, cell monolayers are
incubated with monoclonal and polyclonal antibodies against SNX1 and SNX5 respectively, followed by Alexa-488-conjugated goat-anti-mouse and
Cy3-conjugated goat-anti-rabbit IgG secondary antibodies. B, C, and D: 24 hours post transfection, HEK-Flp-In cells transfected with pEGFP-SNX9 (B),
pEGFP-SNX18 (C) and pEGFP-SNX33 (D) were pulsed with dextran-TR for 5 minutes at 37uC prior to fixation at 4uC in 4% PFA. Images were collected
on an LSM 510 Meta confocal microscope. Scale bar =5 mm.
doi:10.1371/journal.pone.0013763.g004
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screening assay is minimal. Furthermore although the extensive
membrane tubulation driven by elevated levels of SNX-PX-BAR
proteins reduces the surface area and volume of macropinosomes
3–8 minutes post formation [14], the size of these organelles still
significantly exceeds 0.5 mm in diameter by the end of this
timeframe [64]. Hence within the 5 minutes of dextran uptake
measured in the screening assay, it is unlikely that any membrane
tubulation will significantly alter the size of the macropinosomes to
be excluded by the image analysis methodology. Finally the
observation of macropinocytic events within 5 minutes of dextran
internalisation should not be affected by macropinosome degra-
dation through fusion with the late endosomes/lysosomes, as this
late maturation event occurs 20–25 minutes post formation [63].
Thus, it is likely that the screening assay is able to specifically
quantify the number of newly formed macropinosomes without
being confounded by early or late maturation events.
The application of this gain-of-function screening assay to the
SNX-PX-BAR family found that SNX1, SNX5, SNX9, SNX18
and SNX33 all elevated macropinosome formation when
overexpressed. SNX1 has been observed to interact and form
heterodimers with SNX5 by several groups [14,65] in spite of
limited evidence to the contrary [66]. Like SNX5, SNX1
overexpression also changes the frequency of macropinosome
formation, and together with their colocalization on newly formed
macropinosomes early in the formation process suggest that the
two proteins are acting in complex as part of a common
mechanism in macropinocytosis.
It is intriguing that apart from SNX1 and SNX5, the remaining
positive candidates from the gain-of-function screen - SNX9,
SNX18 and SNX33 - all belong to the SH3 subgroup of the SNX-
PX-BAR family. All three SH3 subgroup proteins possess an N-
terminal SH3 domain, which has been shown to be necessary for
interacting with a wide variety of endocytic and actin-regulatory
molecules [46,67]. SNX9 possesses arguably the strongest link to
macropinocytosis, as it has been mechanistically linked to
macropinosome formation by virtue of its role in actin assembly.
It has been demonstrated to drive N-WASP activation at the cell
surface, interact with the Arp2/3 complex, and consequently
promote actin polymerization [40,68]. Moreover, siRNA-mediat-
ed depletion of SNX9 results in a downregulation of fluid-phase
uptake [40].
SNX33 has been shown to interact with SNX9 [54], so it is
likely that they share a similar mechanism of action in elevating
macropinocytosis. SNX33 was also shown to directly interact with
WASP and induce actin-polymerization in the perinuclear space
[54]. However, we were unable to observe SNX33 recruitment on
newly formed macropinosomes or any membrane throughout the
cell, as its subcellular distribution is cytosolic. This may be due to
high overexpression levels perturbing membrane recruitment of
SNX33, as endogenous antibodies to SNX33 have revealed a
punctate distribution throughout the cytoplasm [54]. This may
also be cell-type specific, as a similar recruitment to puncta was
observed by overexpressing an epitope-tagged SNX33 construct in
HeLa cells [46]. As observed cytosolic SNX33 may still interact
with WASP to drive actin polymerization in the pernuclear space,
initiating membrane ruffling and macropinocytosis.
The implication of SNX18 in macropinosome formation further
solidifies the involvement of the SNX-PX-BAR family in
macropinosome formation, and SNX18 can also be found on
early-stage macropinosomes. This result corroborates recent
findings that place SNX18 on circular dorsal ruffles and
membrane ruffles in regulating clathrin-independent fluid-phase
endocytosis [67]. The observation that the protein-scaffolding SH3
domain of SNX18 is required for an elevation in macropinosome
formation may suggest that an intact association between SNX18
and other key molecular effectors is required in driving
macropinocytic uptake. Indeed, SNX18 has been found in
complex with SNX9, N-WASP and dynamin at the cell surface
[46,67] and it is possible that SNX9 and SNX18 regulate
macropinocytosis through a common mechanism. This is likely to
be through the regulator of actin polymerization N-WASP, with
which they both can associate [40,67,68]. Strategic siRNA-
mediated depletion of each of these molecules in turn would shed
Figure 5. The SH3 domain of SNX18 is required for elevation of macropinosome formation. HEK-Flp-In cells transiently overexpressing
pEGFP, pEGFP-SNX18, or pEGFP-DSH3-SNX18 were assayed for macropinosome formation as described in Materials and Methods. The mean number
of macropinosomes/100 transfected cells was quantitated over 3 replicates of 500 transfected cells for each condition. Error bars denote S.E.M.
doi:10.1371/journal.pone.0013763.g005
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PLoS ONE | www.plosone.org 9 October 2010 | Volume 5 | Issue 10 | e13763Figure 6. The modulation of PI(3,4,5)P3 levels affects macropinosome formation. A: HEK-Flp-In cell monolayers were treated with either
65 mM LY294002 or carrier (0.2% Ethanol) for 30 minutes at 37uC prior to pulsing with dextran-TR as described in Materials and Methods in the
continued presence of the drug or carrier. The mean number of macropinosomes/100 cells was quantitated as described in Materials and Methods.
Error bars represent S.E.M. B: HEK-Flp-In cell monolayers transfected with pEGFP-Grp1-PH for 24 hours were imaged using the 1006oil immersion
objective of an Olympus IX-81 OBS Real Time microscope before and after treatment with 65 mM LY294002. Time following LY294002 treatment is
indicated in bottom right hand corner of each panel. C: HEK-Flp-In cells transiently transfected with pIRES2-EGFP, pIRES2-EGFP-PTEN, or pIRES-EGFP-
PTEN(G129E) were co-transfected with pmCherry, pmCherry-SNX9, or pmCherry-SNX18 and assayed for macropinosome formation as described in
Materials and Methods. The mean number of macropinosomes/100 transfected cells was quantitated over 3 replicates of 500 transfected cells for
each condition. Error bars denote S.E.M.
doi:10.1371/journal.pone.0013763.g006
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macropinocytosis.
Given the requirement for PI(3)K activity in macropinocytosis
and the propensity for the PX domain to target proteins to
phosphoinositide-rich membranes [35], a reasonable assumption
would be that the contribution of phosphoinositides is important in
the upregulation of macropinosome formation as mediated by
SNX-PX-BAR proteins. Interestingly, modulating the levels of
PI(3,4,5)P3 by overexpressing PTEN or its phosphatase-deficient
mutant PTEN(G129E) revealed a correlation between PI(3,4,5)P3
levels and macropinosome formation. SNX9 and SNX18 haveboth
been reported to preferentially bind to PI(4,5)P2 [46], potentially
indirectly facilitating the conversion into PI(3,4,5)P3 by interacting
with class I PI(3)K to elevate macropinosome formation. Our
findingsthatcoexpressingPTEN(G129E)andSNX9orSNX18was
synergistic in the elevation of macropinosome formation support
this model, although further work is needed in characterizing
potential interactions between PI(3)K and SNX9 and/or SNX18. It
is unlikely that SNX1 and SNX5 regulate PI(3,4,5)P3 formation
through this mechanism, as SNX1 binds to PI(3)P and PI(3,5)P2
[44], while SNX5 binds to PI(3)P and PI(3,4)P2 [45]. A transition
from PI(3,4,5)P3 toPI(3)Phas been observed onthe macropinosome
shortly post formation however [31,32], and SNX1 and/or SNX5
may be temporally recruited to the macropinosome through the
interaction between their PX domains and PI(3)P. The PI-binding
specificity of SNX33 is still yet to be determined.
In conclusion, the characterization of macropinocytosis requires
the detailed identification of specific molecular components that
regulate different stages of its endocytic lifecycle. This study has
contributed to the understanding of macropinocytosis by uncov-
ering 5 members of the SNX-PX-BAR family in the regulation of
macropinosome formation. By first understanding the molecular
networks involved in the initiation of this endocytic pathway,
further characterization of the downstream coordination required
for subsequent stages in the macropinocytic lifecycle can be
conducted within the appropriate molecular context.
Materials and Methods
Antibodies and DNA constructs
The goat-anti-mouse IgG-Cy3, dextran conjugated to tetra-
methylrhodmaine (dextran-TR) and Alexa647 (dextran-647)
(10,000 MW) antibodies were purchased from Molecular Probes,
Invitrogen (USA). The SNX1 antibody was purchased from BD
transduction laboratories (Australia). The polyclonal SNX5
antibody was a kind gift from Jet Phey Lim (Bio21 Melbourne).
The construct pEGFP-C1 was obtained from Clontech.
pEGFP-Rab5 [69], pEGFP-Rab5Q79L [70], and pEYFP-Raban-
kyrin 5 [34], are as described previously. pIRES2-EGFP-PTEN
and pIRES2-EGFP-PTEN(G129E) were generated by subcloning
the open-reading frames of PTEN and PTEN(G129E) [59] into
pIRES2-EGFP using BamHI and EcoRI. pEGFP-SNX1, pEGFP-
SNX2, pEGFP-SNX4, pEGFP-SNX5, pEGFP-SNX6, pEGFP-
SNX7, pEGFP-SNX8, pEGFP-SNX9, pEGFP-SNX18, pEGFP-
SNX30, pEGFP-SNX32, and pEGFP-SNX33 were generated by
amplifying their full length open reading frame by polymerase
chain reaction (PCR) and the resulting PCR products cloned into
pEGFP-C1. pmCherry-SNX18 was generated by amplifying the
full length open reading frame of SNX18 and cloning the resulting
PCR product into pmCherry-C1. pEGFP-DSH3-SNX18 was
generated by amplifying residues 61-615 of SNX18 and cloning
the resulting PCR product into pEGFP-C1. We thank Dr Heung-
Chin Cheng (The University of Melbourne) for his generosity in
supplying the original PTEN plasmids.
Cell culture and transfection
HEK-Flp-In cells (Invitrogen) were maintained in DMEM
supplemented with 10% (v/v) FCS and 2 mM L-glutamine
(Invitrogen) in a humidified air/atmosphere (5% CO2) at 37uC.
Cells were seeded onto glass coverslips pre-treated with poly-L-
lysine (Sigma, USA), and grown to 90% confluence over 3 days
prior to transfecting with Lipofectamine 2000 as per manufactur-
er’s instructions (Invitrogen). 0.8 mg of DNA was used along with
2 ml of Lipofectamine 2000 per well in a 24 well plate.
EGF treatment and pharmacological agents
EGF and Amiloride were obtained from Sigma (USA).
LY294002 was purchased from Merck (Australia). YM201636
was purchased from Symansis: Cell Signalling Science.
For EGF treatment, cells were serum starved for 16 hours
before being treated in the presence or absence of 100 ng/mL
EGF for various timepoints. Amiloride (1 mM) and LY294002
(65 mM) were each applied to cells at 37uC for 30 minutes. All
experiments following this incubation period were done in the
continued presence of the compound(s).
Streptolysin O permeabilisation
Cell monolayers were transferred to 4uC and washed three
times with 0.45 mM CaCl2 1 mM MgCl2 PBS. The cells were
then treated with 80 U/mL Streptolysin O (Sigma, USA) for 5
minutes at 4uC to only permeabilize the plasma membrane before
washing in 0.45 mM CaCl2 1 mM MgCl2 PBS and incubating
with 37uC PBS for 5 minutes prior to fixation in 4% PFA.
Indirect Immunofluorescence
Cell monolayers were fixed in 4% PFA at 4uC for 30 minutes,
and washed in PBS three times prior to permeabilisation with
0.1% TritonX100 for 10 minutes. Samples were washed in 2%
BSA blocking solution three times, and incubated with the primary
antibody for 1.5 hours at room temperature. The primary
antibody was removed and samples washed again in blocking
solution three times before incubating with appropriate secondary
antibodies conjugated to specific fluorophores for 1 hour at room
temperature. Samples were then washed with blocking solution
and mounted onto microscope slides for imaging.
Live Cell Imaging
HEK-Flp-In cell monolayers were seeded onto 35 mm glass-
bottom dishes (MatTek Corporation) coated with poly-L-lysine
(Sigma-Aldrich). 24 hours post transfection, the samples placed in
10% FCS CO2-independent media (Invitrogen) and maintained at
37uC during live-cell imaging. Using an Olympus IX-81 OBS
Real Time microscope, samples were illuminated with a Xenon
lamp to sequentially capture GFP epifluorescent images on the
1006oil immersion objective.
Macropinosome Formation Screening Assay
HEK-Flp-In cell monolayers were incubated with 100 mg/mL
dextran for 5 minutes at 37uC, before being washed twice with
4uC PBS and fixed in 4uC 4% PFA for 30 minutes. Samples were
then imaged on an LSM 510 Meta confocal scanning microscope
on the 406 objective, capturing 365 mm Z stacks. Macropino-
somes were quantitated by collapsing the Z-stacks of the images
captured using the ‘‘Average Intensity’’ function in ImageJ 1.42q
(NIH). The original RGB image is converted to 8 bit grayscale
format, and the ‘‘Subtract Background’’ functionality employed
with input variable of 8.0 pixels. Macropinosomes were then
selected based on fluorescent intensity (.100) and size (.0.5 mm
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somes within transfected cells, areas of the image corresponding to
macropinosomes are used to create a mask which is then super-
imposed upon the GFP channel and the GFP fluorescent intensity
measured. GFP intensity higher than the background signal (.20)
indicates a macropinosome within a transfected cell. The number
of cells per field of view was quantitated by the number of DAPI-
positive nuclei or GFP-positive cells.
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